Literature DB >> 15905577

Intrinsic resistance of hepatocytes to complement-mediated injury.

Cody A Koch1, Akiyoshi Kanazawa, Ryuta Nishitai, Bruce E Knudsen, Kiyoshi Ogata, Timothy B Plummer, Kim Butters, Jeffrey L Platt.   

Abstract

When activated on or in the vicinity of cells, complement usually causes loss of function and sometimes cell death. Yet the liver, which produces large amounts of complement proteins, clears activators of complement and activated complexes from portal blood without obvious injury or impaired function. We asked whether and to what extent hepatocytes resist injury and loss of function mediated by exposure to complement. Using cells isolated from porcine livers as a model system, we found that, in contrast to endothelial cells, hepatocytes profoundly resist complement-mediated lysis and exhibit normal synthetic and conjugative functions when complement is activated on their surface. The resistance of hepatocytes to complement-mediated injury was not a function of cell surface control of the complement cascade but rather an intrinsic resistance of the cells dependent on the PI3K/Akt pathway. The resistance of hepatocytes to complement might be exploited in developing approaches to the treatment of hepatic failure or more broadly to the treatment of complement-mediated disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905577     DOI: 10.4049/jimmunol.174.11.7302

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  Accommodation of grafts: implications for health and disease.

Authors:  Amy H Tang; Jeffrey L Platt
Journal:  Hum Immunol       Date:  2007-05-15       Impact factor: 2.850

Review 2.  Accommodation in organ transplantation.

Authors:  Raymond J Lynch; Jeffrey L Platt
Journal:  Curr Opin Organ Transplant       Date:  2008-04       Impact factor: 2.640

3.  Human immune reactivity against liver sinusoidal endothelial cells from GalTα(1,3)GalT-deficient pigs.

Authors:  Daan van Poll; Yakoov Nahmias; Alejandro Soto-Gutierrez; Mitra Ghasemi; Hiroshi Yagi; Naoya Kobayashi; Martin L Yarmush; Martin Hertl
Journal:  Cell Transplant       Date:  2010-06-23       Impact factor: 4.064

Review 4.  Redox signaling and the innate immune system in alcoholic liver disease.

Authors:  Jessica I Cohen; Xiaocong Chen; Laura E Nagy
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

5.  Transplantation of hepatocytes from genetically engineered pigs into baboons.

Authors:  Hayato Iwase; Hong Liu; Eva Schmelzer; Mohamed Ezzelarab; Martin Wijkstrom; Hidetaka Hara; Whayoung Lee; Jagjit Singh; Cassandra Long; Eric Lagasse; Jörg C Gerlach; David K C Cooper; Bruno Gridelli
Journal:  Xenotransplantation       Date:  2017-01-28       Impact factor: 3.907

Review 6.  Accommodation in renal transplantation: unanswered questions.

Authors:  Raymond J Lynch; Jeffrey L Platt
Journal:  Curr Opin Organ Transplant       Date:  2010-08       Impact factor: 2.640

Review 7.  Accommodation in ABO-incompatible organ transplants.

Authors:  Mayara Garcia de Mattos Barbosa; Marilia Cascalho; Jeffrey L Platt
Journal:  Xenotransplantation       Date:  2018-05       Impact factor: 3.907

8.  Xenotransplantation: Progress Along Paths Uncertain from Models to Application.

Authors:  Jeffrey L Platt; Marilia Cascalho; Jorge A Piedrahita
Journal:  ILAR J       Date:  2018-12-31

Review 9.  The role of antibodies in transplantation.

Authors:  Alexander T Chang; Jeffrey L Platt
Journal:  Transplant Rev (Orlando)       Date:  2009-07-22       Impact factor: 3.943

Review 10.  Heparan Sulfate Proteoglycan Metabolism and the Fate of Grafted Tissues.

Authors:  Jeffrey L Platt; Lucile E Wrenshall; Geoffrey B Johnson; Marilia Cascalho
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.